123 related articles for article (PubMed ID: 28005468)
1. Age and Its Impact on Outcomes with Intra-Abdominal Infection.
Farmer D; Tessier JM; Sanders JM; Sawyer RG; Rotstein OD; Dellinger EP; Lipsett PA; Cuschieri J; Miller P; Cook CH; Guidry CA; Askari R; Moore BJ; Duane TM
Surg Infect (Larchmt); 2017; 18(2):77-82. PubMed ID: 28005468
[TBL] [Abstract][Full Text] [Related]
2. Does Isolation of Enterococcus Affect Outcomes in Intra-Abdominal Infections?
Sanders JM; Tessier JM; Sawyer R; Dellinger EP; Miller PR; Namias N; West MA; Cook CH; O'Neill PJ; Napolitano L; Rattan R; Cuschieri J; Claridge JA; Guidry CA; Askari R; Banton K; Rotstein O; Moore BJ; Duane TM
Surg Infect (Larchmt); 2017; 18(8):879-885. PubMed ID: 28994635
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of Vancomycin as Part of Broad-Spectrum Coverage Does Not Improve Outcomes in Patients with Intra-Abdominal Infections: A Post Hoc Analysis.
Sanders JM; Tessier JM; Sawyer RG; Lipsett PA; Miller PR; Namias N; O'Neill PJ; Dellinger EP; Coimbra R; Guidry CA; Cuschieri J; Banton KL; Cook CH; Moore BJ; Duane TM
Surg Infect (Larchmt); 2016 Dec; 17(6):694-699. PubMed ID: 27483362
[TBL] [Abstract][Full Text] [Related]
4. Percutaneously drained intra-abdominal infections do not require longer duration of antimicrobial therapy.
Rattan R; Allen CJ; Sawyer RG; Askari R; Banton KL; Coimbra R; Cook CH; Duane TM; OʼNeill PJ; Rotstein OD; Namias N
J Trauma Acute Care Surg; 2016 Jul; 81(1):108-13. PubMed ID: 26953758
[TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
Zakrison TL; Hille DA; Namias N
Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
[TBL] [Abstract][Full Text] [Related]
6. Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.
Rattan R; Allen CJ; Sawyer RG; Askari R; Banton KL; Claridge JA; Cocanour CS; Coimbra R; Cook CH; Cuschieri J; Dellinger EP; Duane TM; Evans HL; Lipsett PA; Mazuski JE; Miller PR; O'Neill PJ; Rotstein OD; Namias N
J Am Coll Surg; 2016 Apr; 222(4):440-6. PubMed ID: 26920994
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
8. Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?
Shah PM; Edwards BL; Dietch ZC; Guidry CA; Davies SW; Hennessy SA; Duane TM; O'Neill PJ; Coimbra R; Cook CH; Askari R; Popovsky K; Sawyer RG
Surg Infect (Larchmt); 2016 Feb; 17(1):27-31. PubMed ID: 26397376
[TBL] [Abstract][Full Text] [Related]
9. Short-Course Antimicrobial Therapy Does Not Increase Treatment Failure Rate in Patients with Intra-Abdominal Infection Involving Fungal Organisms.
Elwood NR; Guidry CA; Duane TM; Cuschieri J; Cook CH; O'Neill PJ; Askari R; Napolitano LM; Namias N; Dellinger EP; Watson CM; Banton KL; Blake DP; Hassinger TE; Sawyer RG
Surg Infect (Larchmt); 2018; 19(4):376-381. PubMed ID: 29565726
[TBL] [Abstract][Full Text] [Related]
10. Patients with Risk Factors for Complications Do Not Require Longer Antimicrobial Therapy for Complicated Intra-Abdominal Infection.
Rattan R; Allen CJ; Sawyer RG; Mazuski J; Duane TM; Askari R; Banton KL; Claridge JA; Coimbra R; Cuschieri J; Dellinger EP; Evans HL; Guidry CA; Miller PR; O'Neill PJ; Rotstein OD; West MA; Popovsky K; Namias N
Am Surg; 2016 Sep; 82(9):860-6. PubMed ID: 27670577
[TBL] [Abstract][Full Text] [Related]
11. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
[TBL] [Abstract][Full Text] [Related]
12. Current Evaluation of Antibiotic Usage in Complicated Intra-Abdominal Infection after the STOP IT Trial: Did We STOP IT?
Posillico SE; Young BT; Ladhani HA; Zosa BM; Claridge JA
Surg Infect (Larchmt); 2019 Apr; 20(3):184-191. PubMed ID: 30676237
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections.
Chong YP; Bae IG; Lee SR; Chung JW; Jun JB; Choo EJ; Moon SY; Lee MS; Jeon MH; Song EH; Lee EJ; Park SY; Kim YS
PLoS One; 2015; 10(4):e0119956. PubMed ID: 25910171
[TBL] [Abstract][Full Text] [Related]
14. Obesity Is Not Associated with Antimicrobial Treatment Failure for Intra-Abdominal Infection.
Dietch ZC; Duane TM; Cook CH; O'Neill PJ; Askari R; Napolitano LM; Namias N; Watson CM; Dent DL; Edwards BL; Shah PM; Guidry CA; Davies SW; Willis RN; Sawyer RG
Surg Infect (Larchmt); 2016 Aug; 17(4):412-21. PubMed ID: 27027416
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
[TBL] [Abstract][Full Text] [Related]
16. Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?
Hennessy SA; Shah PM; Guidry CA; Davies SW; Hranjec T; Sawyer RG
Surg Infect (Larchmt); 2015 Aug; 16(4):396-400. PubMed ID: 26069990
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study.
Jean SS; Ko WC; Xie Y; Pawar V; Zhang D; Prajapati G; Mendoza M; Kiratisin P; Ramalheira E; Castro AP; Rosso F; Hsueh PR
Int J Antimicrob Agents; 2014 Sep; 44(3):222-8. PubMed ID: 25106073
[TBL] [Abstract][Full Text] [Related]
18. A practice-based observational study identifying factors associated with the use of high-dose tigecycline in the treatment of secondary peritonitis in severely ill patients.
Maseda E; Suárez-de-la-Rica A; Anillo V; Salgado P; Tamayo E; García-Bernedo CA; Ramasco F; Villagrán MJ; López-Tofiño A; Giménez MJ; Granizo JJ; Hernández-Gancedo C; Aguilar L; Gilsanz F
Rev Esp Quimioter; 2015 Feb; 28(1):47-53. PubMed ID: 25690145
[TBL] [Abstract][Full Text] [Related]
19. Global Perspectives in Controversies Related to the Management of Intra-Abdominal Infections.
Khatri R; Sawyer R
Surg Infect (Larchmt); 2020 Sep; 21(7):626-633. PubMed ID: 32543289
[No Abstract] [Full Text] [Related]
20. Practice Patterns for the Use of Antibiotic Agents in Damage Control Laparotomy and Its Impact on Outcomes.
Goldberg SR; Henning J; Wolfe LG; Duane TM
Surg Infect (Larchmt); 2017 Apr; 18(3):282-286. PubMed ID: 28394751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
